Recombinant life attenuated vaccine against Argentine hemorrhagic fever

Project: Research project

Project Details

StatusFinished
Effective start/end date4/1/11 → 3/31/18

Funding

  • National Institute of Allergy and Infectious Diseases: $4,593,370.00